Entrada Therapeutics, Inc. · NASDAQ:TRDA
Todd Foley sold 62,714 Entrada Therapeutics, Inc. shares (Form 4)
Traded Aug 24 to Aug 26, 2026 · Filed Aug 26, 2026
From Aug 24 to Aug 26, 2026, Todd Foley (10% owner) sold 62,714 Entrada Therapeutics, Inc. shares at an average US$7.36 for US$462K, leaving 4,318,348 shares. Filed Aug 26, 2026 (Form 4).
- Sold
- 62,714 shares
- Price
- US$7.36 average (US$7.06 to US$7.54)
- Value
- US$462K
- Holding after
- 4,318,348 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Common Stock | Sale | 21,623 | US$7.34 | 4,359,439 | Indirect |
| Aug 25, 2026 | Common Stock | Sale | 26,522 | US$7.54 | 4,332,917 | Indirect |
| Aug 26, 2026 | Common Stock | Sale | 14,569 | US$7.06 | 4,318,348 | Indirect |
Source
Related
- Entrada Therapeutics, Inc.
- Todd Foley
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · MPM BioVentures 2014 GP LLC · Sep 3, 2026